Back to
Magnetar Financial LLC
REGN21 quarters
Position history for
Magnetar Financial LLC's holdings in Regeneron Pharmaceuticals, Inc.
Yes. Magnetar Financial holds 1,340 shares of REGN (Regeneron Pharmaceuticals), worth $835,543, as of its Q2 2026 13F filing. It increased the position by 210 shares (+18.6%) from Q1 2026. Magnetar Financial has held REGN since Q1 2026, across 2 quarterly 13F filings.
Current Value
$835,543
Current Shares
1,340
Total Value Change
+$451,543
Total Shares Change
+113
Quarter-by-Quarter History
Other major holders of REGN: FMR LLC, VANGUARD GROUP INC